Star Health & Allied Insurance Company Ltd Q2 FY27 results are out (Jul–Sep 2026) →Revenue ₹5,341 Cr +17.1% YoYSee revenue, profit and what management said. You are viewing Q4 FY26.
SH

Star Health & Allied Insurance Company Ltd

Q4 FY26Insurance

Star Health & Allied Insurance Company Q4 FY26 earnings call: Revenue & Margins

Q4 FY26 earnings call: what management said on revenue, margins and capex.

Revenue
₹4,648Cr
+13.9% YoY
+1.8% QoQ
Net profit
₹111Cr
+11000% YoY
−13.3% QoQ
Margin
3.2%
+3.4 pp YoY
−0.6 pp QoQ

What the Q4 FY26 call signalled

1 of 2 strong

RevenueGood growth
MarginMargins steady
Price₹573
Market cap₹34.1K Cr
P/E40.3

The short version

Star Health aims for profitable, sustainable growth rather than just market share expansion. Star Health expects steady growth on an N basis with upwards of 39% growth for FY26.

From Star Health & Allied Insurance Company Ltd's Q4 FY26 earnings-call transcript · updated 24 Aug 2026.

Revenue & Sales Performance

Good growth
  • Star Health aims for profitable, sustainable growth rather than just market share expansion.
  • Fresh retail growth is expected to remain strong with a focus on value and volume; fresh retail growth was 38% YoY in Q4 FY26.
  • New-to-insurance mix remains high (~94%-95% on fresh premium), targeting new, profitable customer cohorts.
  • Company projects NEP growth of upwards of 39% for FY26 and expects this to improve further with long-term policies accruing in NEP.
  • Growth targets include maintaining a steady state industry growth alignment of 70-80% overall.
  • Focus on profitable geographies and segments like SME with growth targets aligned to organizational objectives.

2 more points from Star Health & Allied Insurance Company Ltd's call on revenue

Create a free account to keep reading this call

Profitability & Margins

Star Health expects steady growth on an N basis with upwards of 39% growth for FY26.

Locked: what Star Health & Allied Insurance Company Ltd said on margins

Also locked on this page: fundraising, order book

Free account, 30 seconds. No card needed.

Capital Expenditure Plans

Relevant points indicating investment focus include: - Continued investment in technology platforms, especially the Medi Assist platform for claims processing, improving efficiency and customer experience. - Ongoing digital investments to enhance productivity, service outcomes, platform modernization, workflow automation, and AI deployment. - Significant investment in agent upskilling and technology-enabled Learning & Development to improve productivity and maintain agent stickiness.

2 more points from Star Health & Allied Insurance Company Ltd's call on capex

Create a free account to keep reading this call

Top-ranked in Insurance

Ranked on what management guided this quarter

Guidance-ranked
1Niva Bupa Health
Rev 2Mar 3
2Max Financial
Rev 3Mar 2
3
Rev 3Mar 3
4
Rev 3Mar 3
Sign up free to see 2 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

See what Star Health & Allied Insurance Company Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

See what Star Health & Allied Insurance Company Ltd said on order book & pipeline — free account, 30 seconds.

Star Health & Allied Insurance Company Ltd — Quarterly revenue & net profit

Revenue Net profit
Jun 2025Q1 FY26
Sep 2025Q2 FY26
Dec 2025Q3 FY26
Mar 2026Q4 FY26
Jun 2026Q1 FY27
Sep 2026Q2 FY27

Star Health & Allied Insurance Company Ltd Q4 FY26 results — key figures

Star Health & Allied Insurance Company Ltd Q4 FY26 reported results vs Q4 FY25, ₹ crore
₹ CrQ4 FY26Q4 FY25YoYQ3 FY26QoQ
Revenue4,6484,081+13.9%4,566+1.8%
Operating profit (EBITDA)148-7—172-14%
Operating margin3.2%-0.2%+3.4 pp3.8%-0.6 pp
Profit before tax151-1—173-12.7%
Net profit (PAT)1111+11000%128-13.3%
EPS (₹)1.890.01+18800%2.18-13.3%

Source: reported quarterly figures (Screener), ₹ crore.

Reported quarterly figures (₹ Cr). Latest (Q2 FY27): revenue ₹5.3K Cr, net profit ₹265 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

Others in Insurance this season

  • Max Financial (Q4 FY26)

    Total APE (Annualized Premium Equivalent) for FY’26: Rs 10,502 crore, up 20% YoY from Rs 8,770 crore in FY’25 (Page 4). Key investor presentation takeaways from

  • Go Digit General (Q4 FY26)

    For fiscal years '25 and '26, retail health business is under 6% of total health segment, indicating room for growth. Key concall takeaways from Go Digit…

  • Medi Assist Healthcare Services (Q4 FY26)

    Core group business organic growth currently tracking at 8%-10% (same-store growth). Key concall takeaways from Medi Assist Healthcare Services's Q4 FY26 earnin

  • Niva Bupa Health (Q4 FY26)

    16,000 crores, up from INR 9,433 crores in FY '26. Key concall takeaways from Niva Bupa Health's Q4 FY26 earnings call — and how it ranks against sector peers.

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

Star Health & Allied Insurance Company Ltd and 15K+ more earnings calls,
for less than your morning chai

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were Star Health & Allied Insurance Company Ltd Q4 FY26 results?

Star Health aims for profitable, sustainable growth rather than just market share expansion. Star Health expects steady growth on an N basis with upwards of 39% growth for FY26.

What is Star Health & Allied Insurance Company Ltd share price analysis?

Star Health & Allied Insurance Company Ltd currently shows a moderate growth signal based on ranking data. The stock trades at a P/E of 40.3 with a market cap of ₹34,052 Cr. Investors should review the full earnings analysis for detailed insights.

Keep Star Health & Allied Insurance Company Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.